Jiqing Hao

606 total citations
34 papers, 442 citations indexed

About

Jiqing Hao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jiqing Hao has authored 34 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Jiqing Hao's work include Inflammatory Biomarkers in Disease Prognosis (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Jiqing Hao is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Jiqing Hao collaborates with scholars based in China, United States and Thailand. Jiqing Hao's co-authors include Jiatao Liu, Hao Cheng, Fei Zhong, Fang Wang, Yanfeng Zou, Wenjun Ren, Tai Ma, Guoping Sun, Shuping Xu and Yuxian Shen and has published in prestigious journals such as Scientific Reports, Science Advances and Advanced Science.

In The Last Decade

Jiqing Hao

30 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiqing Hao China 12 190 130 118 115 77 34 442
Yihe Yan China 14 167 0.9× 103 0.8× 138 1.2× 237 2.1× 62 0.8× 37 541
Yongsheng Yang China 12 184 1.0× 143 1.1× 50 0.4× 160 1.4× 115 1.5× 19 537
Duygu Derin Türkiye 12 178 0.9× 81 0.6× 181 1.5× 60 0.5× 79 1.0× 24 424
Xuefei Li China 11 237 1.2× 138 1.1× 208 1.8× 151 1.3× 152 2.0× 23 518
Yanhong Shou China 10 144 0.8× 98 0.8× 42 0.4× 108 0.9× 110 1.4× 17 342
King Xin Koh Singapore 7 242 1.3× 185 1.4× 100 0.8× 38 0.3× 65 0.8× 8 440
Linjun Hu China 13 250 1.3× 211 1.6× 113 1.0× 98 0.9× 89 1.2× 28 482
Shigeru Tsuyuki Japan 10 79 0.4× 80 0.6× 163 1.4× 73 0.6× 50 0.6× 32 378
Liangyu Bie China 14 283 1.5× 219 1.7× 163 1.4× 66 0.6× 124 1.6× 29 567

Countries citing papers authored by Jiqing Hao

Since Specialization
Citations

This map shows the geographic impact of Jiqing Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiqing Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiqing Hao more than expected).

Fields of papers citing papers by Jiqing Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiqing Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiqing Hao. The network helps show where Jiqing Hao may publish in the future.

Co-authorship network of co-authors of Jiqing Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiqing Hao. A scholar is included among the top collaborators of Jiqing Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiqing Hao. Jiqing Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Mengyun, Qing He, Sin Man Lam, et al.. (2025). Targeting lipid scrambling potentiates ferroptosis and triggers tumor immune rejection. Science Advances. 11(33). eadx6587–eadx6587.
2.
Yang, Yang, et al.. (2025). Effect of dietary probiotics intake on cancer mortality: a cohort study of NHANES 1999–2018. Scientific Reports. 15(1). 959–959. 4 indexed citations
3.
4.
Chen, Shasha, et al.. (2024). Dual Activity of Type III PI3K Kinase Vps34 is Critical for NK Cell Development and Senescence. Advanced Science. 11(21). e2309315–e2309315. 6 indexed citations
5.
Yang, Yang, et al.. (2024). Association between dietary flavonol intake and mortality risk in the U.S. adults from NHANES database. Scientific Reports. 14(1). 4572–4572. 8 indexed citations
6.
Hao, Jiqing, et al.. (2024). The Predictive Value of Monocarboxylate Transporter 4 (MCT4) on Lung Adenocarcinoma Patients Treated with PD-1 Inhibitors. Journal of Inflammation Research. Volume 17. 10515–10531. 3 indexed citations
7.
Han, Tingting, et al.. (2023). Effect of adjuvant radiotherapy after breast-conserving surgery in elder women with early-stage breast cancer: a propensity-score matching analysis. Frontiers in Oncology. 13. 1012139–1012139. 1 indexed citations
8.
Zhang, Lu, et al.. (2023). Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer. Journal of Inflammation Research. Volume 16. 3381–3398. 5 indexed citations
9.
Zhang, Dianbao, et al.. (2023). Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells. Journal of Thoracic Disease. 15(4). 1978–1993. 7 indexed citations
10.
Fang, Jingyi, et al.. (2023). Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients. Behavioural Neurology. 2023. 1–8.
11.
Wang, Yonggang, Chang Wang, Yanqiao Zhang, et al.. (2022). Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma. Frontiers in Oncology. 12. 876899–876899. 3 indexed citations
12.
Fang, Yue, et al.. (2022). The Efficacy of the Systemic Immune-Inflammation Index and Prognosis Nutritional Index for the Diagnosis of Venous Thromboembolism in Gastrointestinal Cancers. Journal of Inflammation Research. Volume 15. 4649–4661. 12 indexed citations
13.
14.
Shao, Chunyan, Chenwen Zhu, Yun Zhu, et al.. (2021). Decrease of peripheral blood mucosal‐associated invariant T cells and impaired serum Granzyme-B production in patients with gastric cancer. Cell & Bioscience. 11(1). 12–12. 17 indexed citations
15.
Ma, Tai, et al.. (2020). High Preoperative Fibrinogen and Systemic Inflammation Response Index (F-SIRI) Predict Unfavorable Survival of Resectable Gastric Cancer Patients. Journal of the Korean Gastric Cancer Association. 20(2). 202–202. 14 indexed citations
16.
Liu, Jiatao, et al.. (2020). FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer. Respiratory Research. 21(1). 210–210. 78 indexed citations
17.
18.
Xu, Jing, et al.. (2019). Prognostic value of Ki-67 in stage I non-small-cell lung cancer: A meta-analysis involving 1931 patients. Pathology - Research and Practice. 215(5). 855–860. 17 indexed citations
19.
Qian, Zhe, Ying Hu, Tongmei Zhang, et al.. (2018). Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer. Respiratory Research. 19(1). 262–262. 20 indexed citations
20.
Hao, Jiqing, et al.. (2018). Association between circulating leptin concentration and G-2548A gene polymorphism in patients with breast cancer: a meta-analysis. Archives of Medical Science. 15(2). 275–283. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yihe Yan Breakdown of academic impact, for papers by Yongsheng Yang Breakdown of academic impact, for papers by Duygu Derin Breakdown of academic impact, for papers by Xuefei Li Breakdown of academic impact, for papers by Yanhong Shou Breakdown of academic impact, for papers by King Xin Koh Breakdown of academic impact, for papers by Linjun Hu Breakdown of academic impact, for papers by Shigeru Tsuyuki Breakdown of academic impact, for papers by Liangyu Bie
Rankless by CCL
2026